Meredith Manning

Meredith Manning

Director/Board Member at UNICYCIVE THERAPEUTICS, INC.

Net worth: - $ as of 31/10/2026

54 year
Health Technology
Consumer Services

Profile

Meredith S.
Manning
is currently an Independent Director at Unicycive Therapeutics, Inc. since 2026.
Formerly, Ms. Manning was Vice President-Marketing at Baxter International, Inc. from 2013 to 2015, Chief Commercial Officer at resTORbio, Inc. from 2018 to 2019, Chief Commercial Officer at Soleno Therapeutics, Inc. from 2024 to 2026, and President-Americas at PharmaEssentia Corp.
from 2020 to 2023.
Ms. Manning completed undergraduate studies at The Colorado College and earned an MBA from The University of Chicago Booth School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
28/10/2026 0 ( -.--% ) - $ 31/10/2026

Meredith Manning active positions

CompaniesPositionStart
UNICYCIVE THERAPEUTICS, INC. Director/Board Member 01/10/2026

Former positions of Meredith Manning

CompaniesPositionEnd
SOLENO THERAPEUTICS, INC. Corporate Officer/Principal 15/05/2026
PHARMAESSENTIA CORPORATION Corporate Officer/Principal 01/11/2023
ADICET BIO, INC. Corporate Officer/Principal 06/12/2019
BAXTER INTERNATIONAL INC. Sales & Marketing 01/07/2015
See the detail of Meredith Manning's experience

Education of Meredith Manning

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

56

1st degree connections

7

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies7

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Meredith Manning